Article
- The EMBO Journal (2001) 20, 4122 - 4131
- doi:10.1093/emboj/20.15.4122
Protein phosphatase 2A and its B56 regulatory subunit inhibit Wnt signaling in Xenopus
Xinghai Li1, H.Joseph Yost1, David M. Virshup1,2 and Joni M. Seeling1
- Department of Oncological Sciences and the Center for Children, Huntsman Cancer Institute, University of Utah, Salt Lake City, UT 84112, USA
- Division of Hematology/Oncology, Department of Pediatrics, University of Utah, Salt Lake City, UT 84112, USA
Correspondence to:
Joni M. Seeling, E-mail: jseeling@hci.utah.edu
Received 19 April 2001; Accepted 8 June 2001; Revised 8 June 2001
Abstract
Wnt signaling increases
-catenin abundance and transcription of Wnt-responsive genes. Our previous work suggested that the B56 regulatory subunit of protein phosphatase 2A (PP2A) inhibits Wnt signaling. Okadaic acid (a phosphatase inhibitor) increases, while B56 expression reduces,
-catenin abundance; B56 also reduces transcription of Wnt-responsive genes. Okadaic acid is a tumor promoter, and the structural A subunit of PP2A is mutated in multiple cancers. Taken together, the evidence suggests that PP2A is a tumor suppressor. However, other studies suggest that PP2A activates Wnt signaling. We now show that the B56, A and catalytic C subunits of PP2A each have ventralizing activity in Xenopus embryos. B56 was epistatically positioned downstream of GSK3
and axin but upstream of
-catenin, and axin co-immunoprecipitated B56, A and C subunits, suggesting that PP2A:B56 is in the
-catenin degradation complex. PP2A appears to be essential for
-catenin degradation, since
-catenin degradation was reconstituted in phosphatase-depleted Xenopus egg extracts by PP2A, but not PP1. These results support the hypothesis that PP2A:B56 directly inhibits Wnt signaling and plays a role in development and carcinogenesis.
Keywords:
- B56,
- dephosphorylation,
- PP2A,
- Wnt,
- Xenopus



